1-3 of 3
J. Mark Sloan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Defying the odds: 30 years in AL amyloidosis research—recent barriers to clinical trial enrollment

Clinical Trials & Observations
Vaishali Sanchorawala, Bruna Barroso, Anthony Shelton, Elise Goetz, Lisa Mendelson, Tracy Joshi, Natasha Burke, J. Mark Sloan, Andrew Staron
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5826–5828.
https://doi.org/10.1182/bloodadvances.2024014262
Published: 2024
Journal Articles

Febrile Neutropenia in Patients with Duffy-null Associated Neutrophil Counts and Multiple Myeloma or AL amyloidosis

Maya Abdallah, Frances Arters, Jasmine Patel, Camille V. Edwards, Adam Lerner, Fabio Petrocca, Margaux Dockerty, Brittany Fuller, Alicia Godfrey, Andrew Staron, Vaishali Sanchorawala, J. Mark Sloan, Kimberly A Bertrand, Raphael E. Szalat
Journal: Blood Advances
Blood Adv bloodadvances.2024013453.
https://doi.org/10.1182/bloodadvances.2024013453
Published: 2024
Includes: Supplemental data
Journal Articles

Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis

Clinical Trials & Observations
Andrew Staron, Eric J. Burks, John C. Lee, Shayna Sarosiek, J. Mark Sloan, Vaishali Sanchorawala
Journal: Blood Advances
Blood Adv (2020) 4 (5): 880–884.
https://doi.org/10.1182/bloodadvances.2019001331
Published: 2020